2. Network effect estimates and ranking statistics for mortality.

Acetaminophen Mean SUCRA, 0.87; median rank, 1 (95% CrI, 1‐4)
0.58 ( 0.19, 1.76)	Ibuprofen Mean SUCRA, 0.51; median rank, 2 (95% CrI, 1‐4)
0.58 ( 0.19, 1.69)	0.99 ( 0.66, 1.53)	Indomethacin Mean SUCRA, 0.52; median rank, 2 (95% CrI, 1‐4)
0.49 ( 0.16, 1.36)	0.83 ( 0.57, 1.18)	0.85 ( 0.64, 1.05)	Placebo Mean SUCRA, 0.095; median rank, 4 (95% CrI, 3‐4)

The unlabeled data in the boxes are risk ratios (RRs) and 95% credible intervals (CrIs). A RR >1 suggests that the upper left treatment is associated with a higher risk of having the outcome of interest vs the corresponding lower right treatment and the opposite is true for an RR <1. SUCRA, surface under the cumulative ranking curve